- Home
- OKE vs SNN Comparison
OKE vs SNN Comparison
Compare OKE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKE
- SNN
- Stock Information
- Founded
- OKE 1906
- SNN 1856
- Country
- OKE United States
- SNN United Kingdom
- Employees
- OKE N/A
- SNN N/A
- Industry
- OKE Oil & Gas Production
- SNN Industrial Specialties
- Sector
- OKE Utilities
- SNN Health Care
- Exchange
- OKE Nasdaq
- SNN Nasdaq
- Market Cap
- OKE 47.8B
- SNN 13.2B
- IPO Year
- OKE N/A
- SNN 1999
- Fundamental
- Price
- OKE $72.61
- SNN $37.39
- Analyst Decision
- OKE Buy
- SNN Hold
- Analyst Count
- OKE 14
- SNN 3
- Target Price
- OKE $101.36
- SNN $31.50
- AVG Volume (30 Days)
- OKE 3.2M
- SNN 643.6K
- Earning Date
- OKE 10-28-2025
- SNN 10-30-2025
- Dividend Yield
- OKE 5.67%
- SNN 1.95%
- EPS Growth
- OKE 10.75
- SNN 59.91
- EPS
- OKE 5.12
- SNN 0.56
- Revenue
- OKE $27,953,000,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- OKE $49.08
- SNN $7.75
- Revenue Next Year
- OKE $3.86
- SNN $5.37
- P/E Ratio
- OKE $14.18
- SNN $67.21
- Revenue Growth
- OKE 46.36
- SNN 5.35
- 52 Week Low
- OKE $70.63
- SNN $23.69
- 52 Week High
- OKE $118.07
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- OKE 40.26
- SNN 56.26
- Support Level
- OKE $70.63
- SNN $37.92
- Resistance Level
- OKE $73.87
- SNN $38.59
- Average True Range (ATR)
- OKE 1.47
- SNN 0.40
- MACD
- OKE 0.08
- SNN -0.21
- Stochastic Oscillator
- OKE 34.08
- SNN 38.05
About OKE ONEOK Inc.
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation and natural gas liquids transportation and fractionation. It also operates a refined product and crude oil segment connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.